Learn the FDA-approved peptide PT-141 dosage (1.75 mg subcutaneous), plus research doses, timing, side effects, and safety warnings for men and women.
The FDA-approved dosage of PT-141 (bremelanotide, brand name Vyleesi) is 1.75 mg injected subcutaneously at least 45 minutes before anticipated sexual activity. You should not use more than one dose in 24 hours or more than eight doses in a month. PT-141 is approved only for premenopausal women with hypoactive sexual desire disorder (HSDD), not for men or for general sexual enhancement.
What Is PT-141 and How Does the Standard Dosage Work?
PT-141 is a synthetic peptide that activates melanocortin receptors in the brain. This action can influence sexual desire, but researchers do not fully understand the exact mechanism. It is not a hormone like testosterone, and it does not work by increasing blood flow to the genitals.
The standard dose is 1.75 mg under the skin. A healthcare provider prescribes Vyleesi as a single-use auto-injector. You inject it into the thigh or abdomen. The medication takes effect in about 45 minutes to 1 hour. PT-141 was originally studied as a sunless tanning agent, but researchers noticed it increased sexual desire. The FDA approved bremelanotide in 2019 for HSDD.
PT-141 Dosage Chart: Approved, Compounded, and Research Use
Different forms of PT-141 exist, and their doses are not interchangeable. The table below compares the most common options.
| Form and Route | Typical Dose | Timing | Status |
|---|---|---|---|
| Vyleesi (bremelanotide) subcutaneous injection | 1.75 mg | 45 minutes before activity | FDA-approved for premenopausal women with HSDD |
| Compounded PT-141 subcutaneous | 1-2 mg (varies by provider) | 30-60 minutes before | Not FDA-approved; requires a prescription |
| PT-141 nasal spray | 10 mg (investigational) | 30-45 minutes before | Not FDA-approved; used in some studies |
| PT-141 10 mg vial for injection | Supply size, not a single dose | Reconstitute and measure 1.75 mg per dose | Requires sterile technique and medical supervision |
A pt-141 peptide dosage chart from a clinic or online vendor may show different numbers, but only the 1.75 mg subcutaneous dose is FDA-approved. Always follow the prescription and instructions from a licensed healthcare provider.
How Route of Administration Affects PT-141 Dosing
Subcutaneous injection is the only approved route for PT-141. It delivers the peptide into fatty tissue, where it is absorbed steadily. A pt-141 dosage subcutaneous schedule is simple: one injection, as needed, with at least 24 hours between doses.
A pt-141 peptide nasal spray is not FDA-approved. Nasal absorption is less predictable, and studies have used much higher doses, such as 10 mg. The nasal spray dosage in research settings does not match the approved injectable dose.
PT-141 Dosage for Women and Men
For premenopausal women with HSDD, the approved dose is 1.75 mg subcutaneously. A search for pt-141 10mg dosage women often refers to a 10 mg vial of compounded peptide. That 10 mg is the total amount in the vial, not the dose per injection; you would reconstitute it and measure 1.75 mg for each dose.
PT-141 is not FDA-approved for men. Clinical studies in men have tested 1.75 mg subcutaneous and 10 mg intranasal, but results have been mixed. The peptide pt 141 dosage for men in compounded or research settings is not standardized and should only be used under medical supervision. Men should not use PT-141 without a prescription, and no approved product exists for male use. Some men obtain compounded PT-141, but dosing errors can lead to severe nausea or blood pressure changes.
Side Effects and Safety Warnings for PT-141
Common side effects of PT-141 include nausea, flushing, headache, and injection site reactions. Some people also experience a temporary increase in blood pressure. Hyperpigmentation (darkening of the skin) can occur with frequent use.
Do not use PT-141 if you have uncontrolled high blood pressure, known cardiovascular disease, or if you are pregnant. PT-141 is not a cure for sexual desire problems, and it does not treat erectile dysfunction. Talk to a healthcare professional before using any peptide.
Alcohol may worsen nausea and flushing, so it is best to avoid drinking before or after using PT-141.
Online reviews often focus on side effects and timing, but they are not a substitute for medical advice.
Legal Status and Sourcing: What to Know Before You Buy
In the United States, PT-141 is available only by prescription as Vyleesi. Compounded versions require a prescription from a licensed compounding pharmacy. Buying peptides from unregulated online vendors is risky because there is no quality control, and the product may be contaminated or incorrectly dosed.
A search for PT-141 to buy online in the USA may return research chemical sites, but these products are not FDA-approved and may be unsafe. Always get PT-141 from a licensed pharmacy with a valid prescription. Do not use peptides from unverified sources. The FDA has warned consumers about online peptide sellers that make false claims. If a website sells PT-141 without requiring a prescription, it is not a legitimate pharmacy.
Frequently Asked Questions
How long before sex should I take PT-141?
The FDA-approved timing is at least 45 minutes before anticipated sexual activity. The effect may last for several hours, but you should not take more than one dose in 24 hours. Do not take more than eight doses per month.
Can men use PT-141, and what dose is recommended?
PT-141 is not FDA-approved for men, so there is no recommended dose. Research studies have tested 1.75 mg subcutaneous and 10 mg intranasal in men, but results are mixed. Men should only use PT-141 under a healthcare provider's supervision.
Is PT-141 available over the counter?
No. In the United States, PT-141 is available only by prescription as Vyleesi. Compounded PT-141 also requires a prescription from a licensed pharmacy. Buying PT-141 from unregulated online vendors is risky and may be illegal.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.